Assessing the quality of intervention reporting in dermatology randomized controlled trials using the TIDieR checklist.

Randomised controlled trials (RCTs) are central to evidence-based medicine because they support making causal inferences about treatments and mitigate bias through randomisation and blinding.1 However, RCTs have exhibited low-quality methodology2 and reporting,3 which may compromise the trustworthiness and validity of their results. Critics have called for more accurate and detailed reporting of RCT interventions4 ,5 to enable reproduction of the original trial. Interventions that are poorly reported may be unusable by dermatologists who seek to translate the evidence-based research findings to daily practice.